查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1614415

氟二酮市場：按純度、應用和最終用戶 - 2025-2030 年全球預測

Fluindione Market by Purity (95%, >= 98%), Application (Anticoagulating Treatment, Permanent Atrial Fibrillation, Pulmonary Embolism), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年氟二酮市值為9.199億美元，預計到2024年將達到9.7151億美元，複合年成長率為5.69%，到2030年將達到13.5551億美元。

Fluindione 是一種抗凝血藥物，主要用於預防和治療深層靜脈栓塞症和肺動脈栓塞等疾病，降低血栓風險。這項需求源自於由於世界老化導致心血管和血栓症相關疾病日益流行，從而產生了對抗凝血治療的巨大需求。主要應用在醫療機構、醫院和臨床環境中，抗凝血治療的準確性受到嚴格控制。最終用途包括有中風風險的患者、接受手術的患者以及需要有效和安全的管理通訊協定的患有血栓相關疾病的患者。

主要市場統計
基準年[2023] 9.199 億美元
預計年份 [2024] 97151萬美元
預測年份 [2030] 1,355.51 百萬美元
複合年成長率（%） 5.69%

隨著預防保健意識的提高、藥物配方的進步以及專注於提高療效和減少副作用的臨床試驗數量的增加，氟二酮市場正在形成。關鍵的成長要素包括不斷發展的醫療基礎設施、增加的研發投資以及加強抗凝血治療框架的有利政府政策。在醫療保健創新和有利的人口結構推動下，新興市場存在潛在的成長機會。透過策略夥伴關係和創新，公司可以開拓開拓的市場，擴大治療適應症，並改善給藥方案以獲得更好的安全性。

然而，嚴格的監管核准、副作用管理和新型抗凝血劑的競爭等挑戰可能會阻礙市場成長。此外，不良藥物交互作用的風險限制了其廣泛應用，特別是在老年人常見的多重用藥場景。

創新可能集中在開發新的給藥方法、精確劑量演算法和病患監測技術，以確保有效性和安全性。用於個人化醫療和即時劑量調整的人工智慧驅動的自動化系統是有前途的領域。市場是動態的，需要持續研究以適應監管變化、技術進步和患者人口統計的變化。為了實現永續成長，研究市場中的公司需要保持研究突破，專注於以患者為中心的創新，並建立策略夥伴關係以提高競爭力。

市場動態：揭示快速發展的完整 Indion 市場的關鍵市場洞察

供給和需求的動態相互作用正在改變整個印度市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 需要抗凝血治療的疾病增加
    • 改善並擴大全球醫療保健基礎設施
  • 市場限制因素
    • 對副作用和與其他藥物相互作用的擔憂
  • 市場機會
    • 全球正在開發新的藥物輸送系統
    • 氟喹酮新治療應用的研究
  • 市場挑戰
    • 嚴格的藥品核准監理流程

波特五力：駕馭全英吉安市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解整個印度酮市場的外部影響

外部宏觀環境因素在塑造 Full Indion 市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解整個印度市場的競爭狀況

對 Full Indion 市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣 Full Indion 市場供應商績效評估

FPNV 定位矩陣是評估 Full Indion 市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

戰略分析和建議描繪了在全印度市場的成功之路

對於想要加強在全球市場的影響力的公司來說，對 Full Indion 市場進行策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 需要抗凝血治療的疾病增加
      • 改善並擴大全球醫療保健基礎設施
    • 抑制因素
      • 對副作用和與其他藥物相互作用的擔憂
    • 機會
      • 世界各地正在開發新的藥物輸送系統
      • 氟二酮其他治療應用的研究
    • 任務
      • 嚴格的藥品核准監理流程
  • 市場區隔分析
    • 純度：為了滿足活性藥物成分 (API) 的嚴格要求，98% 或更高的純度現在是全茚二酮的首要任務。
    • 應用：擴大氟二酮在抗凝血治療的應用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 完全的印度酮市場純淨度

  • 95%
  • >=98%

第7章完整的印度酮市場：依應用分類

  • 抗凝血治療
  • 持續性心房顫動
  • 肺動脈栓塞
  • 靜脈血栓症

第8章完整的印度酮市場：按最終用戶分類

  • 醫院/診所
  • 長期照護設施

第9章 南北美洲完整的印度酮市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太全印度市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲的完整Indion市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Helicomer 獲得 NIH 200 萬美元津貼用於抗凝血藥物開發
  • 戰略分析和建議

公司名單

  • 1PlusChem LLC
  • Angene
  • Cayman Chemical Company
  • Clearsynth
  • DC Chemicals
  • Henan Bon Industrial Co.,Ltd.
  • Manus Aktteva Biopharma LLP
  • Merck KGaA
  • Prime Pharmaceuticals Pvt. Ltd.
  • Shodhana Laboratories Pvt. Ltd.
  • TargetMol Chemicals Inc.
  • TEBU-BIO LIMITED
Product Code: MRR-757B1C9CB035

The Fluindione Market was valued at USD 919.90 million in 2023, expected to reach USD 971.51 million in 2024, and is projected to grow at a CAGR of 5.69%, to USD 1,355.51 million by 2030.

Fluindione is an anticoagulant medication primarily used for preventing and treating conditions such as deep vein thrombosis and pulmonary embolism by reducing the risk of blood clots. Its necessity stems from the rising prevalence of cardiovascular diseases and thrombosis-related conditions, amplified by aging populations globally, creating a substantial demand for anticoagulant therapies. Its primary application is within healthcare institutions, hospitals, and clinical settings, where precision in anticoagulant therapy is critically managed. The end-use scope extends to patients at risk of stroke, those undergoing surgeries, or individuals with clot-related disorders necessitating effective and safe management protocols.

KEY MARKET STATISTICS
Base Year [2023] USD 919.90 million
Estimated Year [2024] USD 971.51 million
Forecast Year [2030] USD 1,355.51 million
CAGR (%) 5.69%

The market for Fluindione is shaped by increasing awareness about preventive healthcare, advancements in drug formulations, and a rising number of clinical trials focused on enhancing efficacy and reducing side effects. Key growth factors include evolving healthcare infrastructure, increasing investments in research & development, and favorable government policies fortifying anticoagulation treatment frameworks. Opportunities present in emerging markets driven by healthcare innovations and favorable demography can unlock potential growth avenues. Companies could explore untapped markets, expand therapeutic indications, or refine dosage regimens for better safety profiles through strategic partnerships and innovations.

However, challenges such as stringent regulatory approvals, side effects management, and competition from newer anticoagulants could hinder market growth. Moreover, the risk of adverse drug interactions, especially in polypharmacy scenarios common among the elderly, limits its expansive application.

Innovation could focus on developing novel delivery methods, precision dosing algorithms, or enhanced patient monitoring technologies that ensure efficacy and safety. Automated systems leveraging AI for personalized medicine and real-time dose adjustments represent promising areas. The market is dynamic, with continuous research required to adapt to regulatory changes, technological advancements, and shifts in patient demographics. For sustainable growth, companies in the Fluindione market should stay abreast of research breakthroughs, focus on patient-centric innovations, and establish strategic partnerships to enhance their competitive edge.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Fluindione Market

The Fluindione Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising cases of conditions requiring anticoagulation therapy
    • Improvements and expansions in the global healthcare infrastructure
  • Market Restraints
    • Concerns related to adverse effects and interactions with other medications
  • Market Opportunities
    • Ongoing development of novel drug delivery systems globally
    • Research into additional therapeutic applications of fluindione
  • Market Challenges
    • Stringent regulatory processes for drug approval

Porter's Five Forces: A Strategic Tool for Navigating the Fluindione Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Fluindione Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Fluindione Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Fluindione Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Fluindione Market

A detailed market share analysis in the Fluindione Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Fluindione Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Fluindione Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Fluindione Market

A strategic analysis of the Fluindione Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Fluindione Market, highlighting leading vendors and their innovative profiles. These include 1PlusChem LLC, Angene, Cayman Chemical Company, Clearsynth, DC Chemicals, Henan Bon Industrial Co.,Ltd., Manus Aktteva Biopharma LLP, Merck KGaA, Prime Pharmaceuticals Pvt. Ltd., Shodhana Laboratories Pvt. Ltd., TargetMol Chemicals Inc., and TEBU-BIO LIMITED.

Market Segmentation & Coverage

This research report categorizes the Fluindione Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Purity, market is studied across 95% and >= 98%.
  • Based on Application, market is studied across Anticoagulating Treatment, Permanent Atrial Fibrillation, Pulmonary Embolism, and Venous Thrombosis.
  • Based on End-User, market is studied across Hospitals & Clinics and Long-Term Care Facilities.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising cases of conditions requiring anticoagulation therapy
      • 5.1.1.2. Improvements and expansions in the global healthcare infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns related to adverse effects and interactions with other medications
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing development of novel drug delivery systems globally
      • 5.1.3.2. Research into additional therapeutic applications of fluindione
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory processes for drug approval
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Purity: Increasing preference for >=98% purity in fluindione for meeting stringent requirements for active pharmaceutical ingredients (APIs)
    • 5.2.2. Application: Expanding application of fluindione for anticoagulating treatment
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Fluindione Market, by Purity

  • 6.1. Introduction
  • 6.2. 95%
  • 6.3. >= 98%

7. Fluindione Market, by Application

  • 7.1. Introduction
  • 7.2. Anticoagulating Treatment
  • 7.3. Permanent Atrial Fibrillation
  • 7.4. Pulmonary Embolism
  • 7.5. Venous Thrombosis

8. Fluindione Market, by End-User

  • 8.1. Introduction
  • 8.2. Hospitals & Clinics
  • 8.3. Long-Term Care Facilities

9. Americas Fluindione Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Fluindione Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Fluindione Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Helixomer awarded $2M NIH grant for anticoagulant development
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 1PlusChem LLC
  • 2. Angene
  • 3. Cayman Chemical Company
  • 4. Clearsynth
  • 5. DC Chemicals
  • 6. Henan Bon Industrial Co.,Ltd.
  • 7. Manus Aktteva Biopharma LLP
  • 8. Merck KGaA
  • 9. Prime Pharmaceuticals Pvt. Ltd.
  • 10. Shodhana Laboratories Pvt. Ltd.
  • 11. TargetMol Chemicals Inc.
  • 12. TEBU-BIO LIMITED

LIST OF FIGURES

  • FIGURE 1. FLUINDIONE MARKET RESEARCH PROCESS
  • FIGURE 2. FLUINDIONE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FLUINDIONE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FLUINDIONE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL FLUINDIONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL FLUINDIONE MARKET SIZE, BY PURITY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL FLUINDIONE MARKET SIZE, BY PURITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL FLUINDIONE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL FLUINDIONE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL FLUINDIONE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL FLUINDIONE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS FLUINDIONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS FLUINDIONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES FLUINDIONE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES FLUINDIONE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC FLUINDIONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC FLUINDIONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA FLUINDIONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA FLUINDIONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. FLUINDIONE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. FLUINDIONE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FLUINDIONE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FLUINDIONE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL FLUINDIONE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL FLUINDIONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. FLUINDIONE MARKET DYNAMICS
  • TABLE 7. GLOBAL FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL FLUINDIONE MARKET SIZE, BY 95%, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL FLUINDIONE MARKET SIZE, BY >= 98%, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL FLUINDIONE MARKET SIZE, BY ANTICOAGULATING TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL FLUINDIONE MARKET SIZE, BY PERMANENT ATRIAL FIBRILLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL FLUINDIONE MARKET SIZE, BY PULMONARY EMBOLISM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL FLUINDIONE MARKET SIZE, BY VENOUS THROMBOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL FLUINDIONE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL FLUINDIONE MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS FLUINDIONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES FLUINDIONE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC FLUINDIONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA FLUINDIONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. FLUINDIONE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. FLUINDIONE MARKET, FPNV POSITIONING MATRIX, 2023